Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium
Zhe Zhou(RWTH Aachen University), Andreas Schober(German Centre for Cardiovascular Research), Ela Karshovska(Ludwig-Maximilians-Universität München), Markus Reinholz(LMU Klinikum), Pallavi Subramanian(RWTH Aachen University), Jean Sébastien Saulnier‐Blache(Université Toulouse III - Paul Sabatier), Gueler Sevilmis(Ludwig-Maximilians-Universität München), Jerold Chun(Sanford Burnham Prebys Medical Discovery Institute), Kathrin Heyll(RWTH Aachen University), Brigitta Globke(Ludwig-Maximilians-Universität München), Marc van Zandvoort(Maastricht University Medical Centre), Christian Weber(Munich Cluster for Systems Neurology), Remco T. A. Megens(Maastricht University), Oliver Soehnlein(University of Münster)
Cited by 219
Related Papers
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain
|Nature Biotechnology|2017|1.1k
Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain
|Science|2016|1.1k
LPA Receptors: Subtypes and Biological Actions
|The Annual Review of Pharmacology and Toxicology|2010|851
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
|Nature Medicine|2007|820
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
|Clinical Neuropharmacology|2010|794